Phil Choi: New Guidance Aims to Improve Care for Patients With AIHA
Phil Choi, Associate Professor at The Australian National University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Internal Medicine Journal, adding:
”So proud of our collaborative effort to provide guidance in Australia and New Zealand for the management of autoimmune haemolytic anaemia (AIHA).
AIHA has higher mortality rates than many haematology malignancies but gets so little attention in clinical training, research and novel drug development.
Hopefully our work will put the spotlight on this disease and kick start renewed interest in improving outcomes for these patients.”
Title: AustrAIHANZ – consensus guidelines on the investigation and management of autoimmune haemolytic anaemia in Australia and New Zealand
Authors: Philip Choi, Eileen Merriman, Ashwini Bennett, Anoop Enjeti, Chee Wee Tan, Isaac Goncalves, Danny Hsu, Jun Yen Ng, Anastazia Keegan, Robert Bird
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 13:55Marilena Vrana: Building Momentum for the Future of Plasma-Derived Therapies
-
Nov 10, 2026, 13:32Maya Bishop: Scientific Exchange and Global Connections at AHA 2026
-
Nov 10, 2026, 13:10Alan Nurden։ How Aberrant Splicing Disrupts Megakaryocyte Development in TAR Syndrome
-
Nov 10, 2026, 13:10Masanori Aikawa: NEK7 Research Earns Top Honors at AHA 2026
-
Nov 10, 2026, 12:57Chokri Ben Lamine: The Hidden Risk of RBC Alloimmunization in SCD, Thalassemia and HSCT
-
Nov 10, 2026, 12:47Jamie Nash։ RBC-Derived EVs Show Greater Procoagulant Potential
-
Nov 10, 2026, 11:14Judith Catella: SVC Filters in Upper Extremity DVT Thrombectomy
-
Nov 10, 2026, 11:11Roberta Gualtierotti: Oral Signs of Systemic Immune-Mediated Diseases
-
Nov 10, 2026, 11:08Tim Brümmendorf: FlowFISH in New ASH Guidelines for Aplastic Anemia